Navigation Links
Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus
Date:11/9/2010

ific body systems after treatment with epratuzumab.  Improvements were particularly prominent in cardiorespiratory and neuropsychiatric systems in which symptom improvements are often difficult to achieve.

These results demonstrated that in a patient population with predominantly high or severe disease activity, differences in responder rates between the epratuzumab 600mg weekly and 1200mg every other week groups, and the placebo group was observed as early as week 12, with the emergence of improvements apparent in week 8.

In two previous phase II randomized controlled trials, epratuzumab treatment resulted in clinically meaningful reduced disease activity, improved health-related quality of life (HRQoL) measurements and reduced reliance on corticosteroids compared to placebo treatment in patients with active moderate and severe SLE.

"We are pleased by the repeated consistency of symptom improvement demonstrated by epratuzumab in all our clinical studies to date and we look forward to confirming these results in our phase 3 studies due to start later this year," said Prof. Dr. Iris Loew-Friedrich, Chief Medical Officer of UCB. She added, "Achieving a BILAG improvement, especially at an early timepoint seen in EMBLEM™, is a hopeful sign of the drug's future potential."

Epratuzumab is a humanized monoclonal antibody targeting CD22 and modulating B cell activity.  Although the exact role of CD22 is not fully understood, it is considered to be a regulator of B cell function. B cells are known to contribute to SLE by producing antibodies against the body's own cells and tissues, causing the immune system to turn on itself, resulting in inflammation and tissue damage. Epratuzumab is an anti-B-cell therapeutic, because of its ability to modulate B cell function without depleting a large portion of these lymphocytes.

* This study was not powered to detect statistical differences between treatment arms (p values were no
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Research and Markets has ... Therapeutics Market & Pipeline Insight 2014" report to ... to prevent and eradicate the prevalence of cancer have ... confined to low specificity, safety and large number of ... a better solution. It has been discovered that peptides ...
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... Where do you start when trying to minimize the ... independent nonprofit that researches the best approaches to improving patient ... its 5th annual list of Top 10 Health Technology ... download with registration, the list features the top 10 ...
... Dec. 7, 2010 Millennium Research Group (MRG), the ... release their latest data on the US clot management ... for Clot Management Devices 2011 report provides important ... and the complex competitive dynamics of medical device manufacturers ...
Cached Medicine Technology:ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 2ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 3Millennium Research Group to Release Their Latest US Clot Management Data 2
(Date:8/29/2014)... As reported by CNN.com in the article ... process of admitting that you need help for a prescription ... and highlights the fact that if you simply try to ... overwhelmed by all of the information that is available online. ... through, it is still possible to get help. The statistics ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to new ... But Not Peer Pressure, Key to Prescription Drug Misuse Among ... primary focus for 18-29 year olds when it comes to ... the for this age group the real problem which influences ... drug associations and recreational use of them to have fun ...
(Date:8/29/2014)... article entitled How Genes, Gender and Environment Influence Substance ... gender and the environment that an individual is in affect ... Indiana University are taking another look at the fact that ... this factor to what is known about the influences of ... ties can help to reduce a man’s risk for abusing ...
(Date:8/29/2014)... 29, 2014 Formed in 2014, KAJ Brothers ... beyond their years. Their sophisticated Pop/R&B sound, with beautiful ... is fortunate enough to experience every day. , ... uplifted and feeling loved with the primary purpose of elevating ... this, the group unanimously replied - “To make chivalry cool ...
(Date:8/29/2014)... Mirada, CA (PRWEB) August 29, 2014 ... which will give patients the convenience of visiting ... with Healthpointe doctors through telemedicine. , Healthpointe doctors are ... calls (or audio). If necessary, the doctor can even ... assessed the patient’s condition, he or she can prescribe ...
Breaking Medicine News(10 mins):Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 2Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2
... WASHINGTON, June 4 Walgreen Co. of,Deerfield, Ill., ... claims that from,2001 to 2005, it improperly switched ... Fluoxetine and Eldepryl in order to,increase its reimbursement ... which operates over 5,000 retail pharmacies throughout the,U.S., ...
... TORONTO, June 4 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... appeal the,recent decision made by American Stock Exchange (the ... appeal determination process, the,Company,s stock will continue to trade ... to trade on the Toronto Stock Exchange (the "TSX"),under ...
... patients who lose nerve signals , , WEDNESDAY, June 4 ... improved after receiving human neural stem cell transplants, a ... substance that plays a critical role in the transmission ... missing or damaged, electrical signals aren,t properly transmitted. These ...
... (48%) of high,school teens say they have had sex--an increase ... by the Centers for Disease Control,and Prevention. During the same ... used a condom the last time they had sex decreased ... Youth Risk Behavior Surveillance,System. The survey is administered every two ...
... A failed drug launch can cost,a pharmaceutical ... end,up costing a company more. Leading pharmaceutical companies ... sales with a re-launch, according to a,study by ... As best-in-class pharma companies have demonstrated, combining ...
... Two members of Easter Seals national,corporate partner family -- ... across the Chicagoland area to bring value to consumers, ... consumers visiting any Chicagoland CENTURY,21(R) office or open house ... or transferred prescription is brought to CVS/pharmacy for use ...
Cached Medicine News:Health News:Walgreens to Pay $35 Million to U.S., 46 States & Puerto Rico to Settle Medicaid Prescription Drug Fraud Allegations 2Health News:PreMD Appeals American Stock Exchange Delisting Notification 2Health News:Human Stem Cell Transplant Helps Brain-Impaired Mice 2Health News:Teen Sexual Activity Increases, Contraceptive Use Decreases 2Health News:Redefining a Product's Identity Key to a Successful Re-Launch 2Health News:CVS/pharmacy and CENTURY 21(R) Team Up With Easter Seals Around Chicagoland 2
... The Ultra Series features a modernized optical ... which transmits light more efficiently, producing a ... clarity. The breakthrough optical quality of the ... increase in light transmission, a 15% expanded ...
The Marco E-Z Tilt Chair combines the most simplified manual reclining motion with a new modern, sophisticated appearance....
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
Medicine Products: